MXCT
Companies
NASDAQ
MaxCyte Inc.
Health Care
$2.04
-$2.13 (-51.08%)
Price Chart
Overview
About MXCT
MaxCyte is a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization.
Market Cap
$508.1M
Volume
2.5M
Avg. Volume
1.7M
P/E Ratio
-5.833334
Dividend Yield
0.00%
Employees
1.1K
Company Information
Risk & Correlation Analysis
Market Correlation
0.78
Moderate Correlation
Volatility
High (0.56)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, MXCT shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$508.1M
Volume2.5M
P/E Ratio-5.83
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 8, 2024Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025